| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |